1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "220991-20-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-13507


    COX Cancer Metabolic Disease Inflammation/Immunology
    Lumiracoxib is a potent,selective and orally active COX-2 inhibitor with a Ki value of 0.06 μM. Lumiracoxib acts as a nonselective NSAID with anti-inflammatory, analgesic and antipyretic activities. Lumiracoxib can be used for osteoarthritis and bone cancer research.